Home Clinical Topics Drugs and Devices FDA approves first drug for treating spinal muscular dystrophy

FDA approves first drug for treating spinal muscular dystrophy

On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here